PL2709599T3 - Kompozycja farmaceutyczna zawierająca drotawerynę - Google Patents

Kompozycja farmaceutyczna zawierająca drotawerynę

Info

Publication number
PL2709599T3
PL2709599T3 PL12721534T PL12721534T PL2709599T3 PL 2709599 T3 PL2709599 T3 PL 2709599T3 PL 12721534 T PL12721534 T PL 12721534T PL 12721534 T PL12721534 T PL 12721534T PL 2709599 T3 PL2709599 T3 PL 2709599T3
Authority
PL
Poland
Prior art keywords
drotaverine
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
PL12721534T
Other languages
English (en)
Inventor
Sudhakara Rao BADABHAGNI
Nilesh Jaiswal
Praveen Khullar
Kum PRASAD
Original Assignee
Chinoin Private Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Private Co Ltd filed Critical Chinoin Private Co Ltd
Publication of PL2709599T3 publication Critical patent/PL2709599T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
PL12721534T 2011-05-20 2012-05-16 Kompozycja farmaceutyczna zawierająca drotawerynę PL2709599T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN1728CH2011 2011-05-20
US201161499850P 2011-06-22 2011-06-22
EP11305922 2011-07-13
EP12721534.1A EP2709599B1 (en) 2011-05-20 2012-05-16 Pharmaceutical composition comprising drotaverine
PCT/EP2012/059163 WO2012159964A1 (en) 2011-05-20 2012-05-16 Pharmaceutical composition comprising drotaverine

Publications (1)

Publication Number Publication Date
PL2709599T3 true PL2709599T3 (pl) 2018-07-31

Family

ID=47216628

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12721534T PL2709599T3 (pl) 2011-05-20 2012-05-16 Kompozycja farmaceutyczna zawierająca drotawerynę

Country Status (10)

Country Link
US (1) US20140080864A1 (pl)
EP (1) EP2709599B1 (pl)
AR (1) AR086448A1 (pl)
BR (1) BR112013029621A2 (pl)
EA (1) EA022944B1 (pl)
HU (1) HUE038538T2 (pl)
MX (1) MX354485B (pl)
PL (1) PL2709599T3 (pl)
UY (1) UY34081A (pl)
WO (1) WO2012159964A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115279346A (zh) 2020-03-09 2022-11-01 苏什玛·保罗·伯利亚 包含屈他维林或其盐的控制释放制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197207B (en) * 1985-12-04 1989-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient
HUT60926A (en) * 1991-04-12 1992-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition suitable for reducing or preventing increased thrombocyte-aggregation capability
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents

Also Published As

Publication number Publication date
MX2013013574A (es) 2014-09-22
EP2709599A1 (en) 2014-03-26
US20140080864A1 (en) 2014-03-20
EA201391743A1 (ru) 2014-03-31
AR086448A1 (es) 2013-12-11
WO2012159964A1 (en) 2012-11-29
BR112013029621A2 (pt) 2016-12-13
HUE038538T2 (hu) 2018-10-29
MX354485B (es) 2018-03-07
UY34081A (es) 2013-01-03
EA022944B1 (ru) 2016-03-31
EP2709599B1 (en) 2017-12-20

Similar Documents

Publication Publication Date Title
AP3864A (en) Pharmaceutical composition
GB201113662D0 (en) Pharmaceutical compositions
ZA201308208B (en) Pharmaceutical compositions
HRP20181896T1 (hr) Farmaceutske formulacije
HK1199824A1 (en) Pharmaceutical compositions
GB201118232D0 (en) Pharmaceutical composition
SG10201604667YA (en) Pharmaceutical preparation
EP2702989A4 (en) STABLE PHARMACEUTICAL COMPOSITION
HK1189158A1 (en) Pharmaceutical composition
GB201105298D0 (en) Pharmaceutical preparation
GB201118181D0 (en) Pharmaceutical compositions
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
PL2691119T3 (pl) Preparat farmaceutyczny
EP2665480A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING AND USING THEM
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
HUP1100444A2 (en) Pharmaceutical composition
ZA201308414B (en) Solid pharmaceutical composition
PL2709599T3 (pl) Kompozycja farmaceutyczna zawierająca drotawerynę
HUP1100445A2 (en) Pharmaceutical composition
EP2714715A4 (en) PHARMACEUTICAL COMPOSITIONS
ZA201309537B (en) Pharmaceutical composition comprising fexofedine
EP2727594A4 (en) NEW PHARMACEUTICAL COMPOSITION
GB201119796D0 (en) Pharmaceutical comopounds
GB201111577D0 (en) Pharmaceutical formulations